Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, September 2000, p. 2304-2309, Vol. 44, No. 9
0066-4804/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Functional Analysis of the Active Site of a
Metallo-
-Lactamase Proliferating in Japan
Shin
Haruta,
Hitomi
Yamaguchi,
Elise Tie
Yamamoto,
Yoshiro
Eriguchi,
Michiyoshi
Nukaga,
Koji
O'Hara,* and
Tetsuo
Sawai
Division of Microbial Chemistry, Faculty of
Pharmaceutical Sciences, Chiba University, 1-33, Yayoi-cho,
Inage-ku, Chiba 263-8522, Japan
Received 6 July 1999/Returned for modification 8 November
1999/Accepted 9 June 2000
 |
ABSTRACT |
An R-plasmid-mediated metallo-
-lactamase was found in
Klebsiella pneumoniae DK4 isolated in Japan in 1991. The
nucleotide sequence of its structural gene revealed that the
-lactamase termed DK4 was identical to the IMP-1
metallo-
-lactamase which was mediated by a chromosomal gene of
Serratia marcescens TN9106 isolated in Japan in 1991 (E. Osano et al., Antimicrob. Agents Chemother. 38:71-78, 1994). The dose
effect of DK4
-lactamase production on the resistance levels
indicated a significant contribution of the enzyme to bacterial
resistance to all the
-lactams except monobactams. The enzymatic
characteristics of the DK4
-lactamase and its kinetic parameters for
nine
-lactams were examined. The DK4
-lactamase was confirmed to
contain 2 mol of zinc per mol of enzyme protein. The apoenzyme that
lacked the two zincs was structurally unstable, and the activities of
only 30% of the apoenzyme molecules could be restored by the addition
of 1 mM zinc sulfate. The substitution of five conserved histidines
(His28, His86, His88, His149, His210) and a cysteine (Cys168) for an
alanine indicated that His86, His88, and His149 served as ligands to
one of the zincs and that Cys168 played a role as a ligand to the
second zinc. Both zinc molecules contribute to the enzymatic process. Mutant enzymes that lack only one of these retained some activity. Additionally, a conserved aspartic acid at position 90 was replaced by
asparagine. This mutant enzyme showed an approximately 1,000 times
lower kcat value for cephalothin than that of
the wild-type enzyme but retained the two zincs even after dialysis
against zinc-free buffer. The observed effect of pH on the activity
suggested that Asp90 functions as a general base in the enzymatic process.
 |
INTRODUCTION |
-Lactamases (EC 3.5.2.6) are the
bacterial enzymes that hydrolyze the
-lactam amide bond of
-lactam antibiotics, and their production is the most common
mechanism of bacterial resistance to these antibiotics.
-Lactamases
are divided into four classes, classes A to D, on the basis of their
primary structures (1). The enzymes can also be classified
into two groups on the basis of the differences in their catalytic
mechanisms, i.e., serine
-lactamases (classes A, C, and D) and
metallo-
-lactamases (class B). Metallo-
-lactamases have
broad substrate specificity, including carbapenems, which are otherwise
quite stable to serine
-lactamases. A limited number of bacterial
species were known to produce metallo-
-lactamases; therefore, the
enzymes were thought to be of little consequence clinically. However,
we isolated an R-plasmid-mediated metallo-
-lactamase gene from
Klebsiella pneumoniae DK4 in 1991 (GenBank accession number D29636). This was the first finding of an R-plasmid-mediated metallo-
-lactamase gene in a member of the family
Enterobacteriaceae. On the basis of the nucleotide sequence
of the DK4
-lactamase gene, the DK4 enzyme was confirmed to be
identical to a metallo-
-lactamase mediated by the
blaIMP gene located in the chromosome of a
Serratia marcescens strain isolated in 1991 (18).
Recently, the blaIMP gene has been found to be
widely distributed in clinical isolates in Japan, including among
members of the family Enterobacteriaceae and
Pseudomonas aeruginosa isolates (2, 10, 24).
Although kinetic parameters for common
-lactams were reported
(13, 16, 18), little is known about other molecular
characteristics of the metallo-
-lactamases. The study described here
was carried out to understand the functional properties of the DK4
(IMP-1)
-lactamases by using site-directed mutagenesis.
 |
MATERIALS AND METHODS |
Bacterial strains and plasmids.
K. pneumoniae DK4 is a
clinical strain isolated in 1991 in Tokyo, Japan, and its
-lactam
resistance is mediated by an R plasmid termed RDK4. Escherichia
coli 1037 Rifr (11) was used as the
recipient for R-plasmid transfer. E. coli AS226-51
(27) is an ampD mutant of strain C600 and a
mutant with an ampC deletion and was used as the host for
enzyme preparation. E. coli TG1 (5) was used as
the host for the cloned
-lactamase gene. E. coli MV1184
(28) was used as a recipient for transformation in the
site-directed mutagenesis study. Plasmid pHSG398 (25) was
used as a cloning vector that carries a marker for resistance to
chloramphenicol. Plasmid pKF18K (Takara Shuzo Co., Ltd.), which has a
marker for resistance to kanamycin, was used as the vector for
site-directed mutagenesis.
Media, chemicals, and enzymes.
Nutrient broth and Drigalski
agar (Eiken Chemical Co., Tokyo, Japan) were used as the culture medium
and the selective agar for R-plasmid transfer, respectively. For
transformation, 2× yeast extract-tryptone (2×YT) broth and yeast
extract-tryptone (YT) agar were used. For
-lactamase preparation,
the bacteria were grown in heart infusion broth (Eiken Chemical Co.) or
Terrific broth. Heart infusion agar was used to measure the
susceptibilities of the bacteria to
-lactams.
The enzymes and enzyme kits used for DNA technology procedures were
purchased from Takara Shuzo Co. (Shiga, Japan), Toyobo Co. (Osaka,
Japan), and Wako Junyaku Co. (Tokyo, Japan).
[
32-P]dCTP was purchased from Amersham
(Buckinghamshire, United Kingdom). The following antibiotics and
-lactamase inhibitors used in this study were kindly provided by the
indicated pharmaceutical companies: benzylpenicillin and kanamycin,
Meiji Seika Kaisha, Ltd. (Tokyo, Japan); cephalothin, Shionogi & Co.
(Osaka, Japan); cefuroxime, Nippon Glaxo Ltd. (Tokyo, Japan); imipenem,
cefoxitin, and cilastatin, Banyu Pharmaceutical Co. (Tokyo, Japan);
sulbactam, Pfizer Pharmaceuticals Inc. (Tokyo, Japan); clavulanic acid,
SmithKline Beecham (Tokyo, Japan); chloramphenicol, Yamanouchi
Pharmaceutical Co. (Tokyo, Japan); a chromogenic cephalosporin
(FR18419), Fujisawa Pharmaceutical Co. (Osaka, Japan); rifampin,
Daiichi Pharmaceutical Co. (Tokyo, Japan); and aztreonam, Eisai Co.
(Tokyo, Japan).
Antibiotic susceptibility testing.
Bacterial susceptibility
to antibiotics was measured by the serial agar dilution method by a
previously described procedure (23) and was expressed as the
MIC of each drug.
Cloning of
-lactamase gene.
RDK4 DNA was prepared from
E. coli AS226-51/RDK4 by the alkaline lysis method and was
digested with a restriction endonuclease, PstI. The digested
DNA fragments were ligated into the PstI site of a vector
plasmid, pHSG398. The resultant recombinant plasmid DNA was confirmed
to have incorporated a 9.7-kb DNA fragment and was designated pDK4-1.
The pDK4-1 DNA was retransferred into E. coli AS226-51,
which was confirmed to produce a
-lactamase with a pI of 8.3, identical to that of the DK4
-lactamase. A 1.2-kb DNA fragment was
finally prepared by digestion of pDK4-1 with StyI, and the
fragment was confirmed to include the intact
-lactamase gene by
blunt-ending analysis. The fragment was inserted antiparallel with
respect to the lacZ direction into the HincII
site of pHSG398. The cloned plasmid DNA was termed pDK4-5. The 1.2-kb
DNA fragment was sequenced by the dideoxynucleotide chain-termination
method (21) with a BcaBEST dideoxy sequencing kit
(Takara Shuzo Co., Kyoto, Japan).
Site-directed mutagenesis.
Site-directed mutagenesis was
carried out by use of the oligonucleotide-directed dual amber method
(9) with a template plasmid clone, pKFDK4. The template
plasmid was prepared by insertion of the 1.2-kb DNA fragment containing
the
-lactamase gene into pKF18K antiparallel with respect to the
lacZ direction. The entire mutant gene was sequenced by the
dideoxy chain-termination method to confirm the desired exchange in the
nucleotide sequence.
Isoelectric focusing.
Isoelectric focusing was carried out
by use of a model 111 IEF cell (Bio-Rad Laboratories, Hercules, Calif.)
and a gel plate containing 5% Ampholine (pH 3.5 to 9.5). The
-lactamase activity on the plate was detected by spraying with a
chromogenic cephalosporin, FR18419. The
-lactamases from the
following strains were used as isoelectric markers: Citrobacter
freundii GN346, pI 8.9 (22); Proteus
mirabilis N29/pCS229, pI 6.9 (20); and E. coli ML1410/RGN823, pI 5.4 (22).
-Lactamase purification and
-lactamase assay.
E.
coli AS226-51 cells carrying the wild-type or a mutant
-lactamase gene were grown overnight at 37°C in heart infusion broth or Terrific broth containing a sublethal concentration of kanamycin (50 µg/ml). The preculture was diluted with a 40-fold volume of fresh medium, followed by growth under aeration at 37 or
24°C. In the cases of the bacterial cells carrying the mutant gene
with the H28A, H86A, H88A, H149A, and C168A mutations, bacterial growth
was carried out at 24°C to achieve a higher yield of the active
enzyme than that achieved at 37°C. At the mid-logarithmic phase the
bacterial cells were disrupted with a French press in 50 mM MOPS
[3-(N-morpholino)propanesulfonic acid] buffer (pH 7.0) containing 0.1 mM zinc sulfate. The disrupted cells were centrifuged for 1 h at 40,000 × g and 4°C, and the
supernatant was used for further purification of the enzyme by
ion-exchange chromatography on a CM-Sephadex C-50 column equilibrated
in MOPS buffer with 0.1 mM zinc sulfate. The enzyme was eluted from the
column by a linear NaCl gradient (0.1 to 0.4 M), followed by gel
filtration on a Sephadex G-75 column equilibrated with MOPS buffer. The
-lactamase in the fractions was detected by cephalothin hydrolysis
in 50 mM MOPS buffer (pH 7.0) with 1 mM zinc sulfate or by an
immunoblotting technique with the polyclonal antiserum against the DK4
-lactamase. The purity of the enzyme preparation was confirmed by
sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE).
The enzyme protein was determined from UV absorption at 280 nm with
equal to 44,600 M
1 cm
1. Confirmation was
obtained by the Bio-Rad version of Bradford's dye binding assay
(4) with bovine serum albumin as a standard.
-Lactamase activity, unless stated otherwise, was assayed by the UV
spectrophotometric method (30) in 50 mM MOPS buffer (pH 7.0)
at 30°C. For determination of the kcat and the
Km values, the initial velocity at each
substrate concentration was determined by using a spectrophotometer
(U-3300; Hitachi Ltd., Tokyo, Japan), and the kinetic parameters were
calculated by means of nonlinear regression.
Protein analysis.
The N-terminal sequence was determined by
the use of a protein sequencer (model 477A; Applied Biosystems, Foster
City, Calif.).
Atomic absorption spectroscopy.
The zinc content in the
enzyme molecule was determined as follows. All the glassware was washed
with 6 N HNO3 in order to eliminate contamination. Enzyme
samples were subjected to 3 days of dialysis against zinc-free 50 mM
MOPS buffer (pH 7.0) containing Chelex 100 resin at 4°C with multiple
changes of the dialysis buffer, and then the enzyme samples were
diluted with the same buffer to provide samples with the expected range
of 0.05 to 1.00 ppm of zinc. The preparation was analyzed with a Z-8000
Polarized Zeeman Atomic Absorption Spectrophotometer (Hitachi Ltd.).
Nucleotide sequence accession number.
The nucleotide
sequence of the DK4
-lactamase gene was entered into the GSDB, DDBJ,
EMBL, and NCBI nucleotide sequence databases under the accession number
D29636.
 |
RESULTS AND DISCUSSION |
The DK4
-lactamase gene and its product.
K.
pneumoniae DK4 exhibited a high level of resistance to
extended-spectrum cephalosporins and a moderate level of resistance to
carbapenens, i.e., imipenen. The resistance was
conjugally transferred to E. coli 1037 Rifr. The
-lactam resistance was due to a
-lactamase with a pI of 8.6 and
was mediated by an R plasmid termed RDK4. The activity of the DK4
-lactamase was completely inhibited by 10 mM EDTA. The DK4
-lactamase gene in a 9.7-kb DNA fragment was cloned into a plasmid
vector, pHSG398, and the recombinant plasmid was termed pDK4-1. From
the 9.7-kb DNA fragment, four shorter DNA fragments (of 3.9, 2.6, 2.0, and 1.2 kb) containing the
-lactamase gene were prepared, and each
fragment was cloned into the plasmid vector (Fig.
1). The recombinant plasmids obtained
were termed pDK4-2, pDK4-3, pDK4-4, and pDK4-5, respectively. The
complete nucleotide sequence of the 1.2-kb fragment inserted into
pDK4-5 was determined. The sequenced region contained an open reading
frame, and an amino acid sequence comprising 246 amino acids was
deduced. Through determination of the N-terminal amino acid sequence of
the purified enzyme protein, a signal peptide with 18 amino acids and a
mature enzyme with 228 amino acids were detected.
Alignment of the mature enzyme with known metallo-
-lactamase amino
acid sequences indicated that the DK4
-lactamase has 38.4% homology
to the enzymes of Bacillus cereus 5/B/6 (15), 35.4% homology to the enzyme of Bacteroides fragilis
TAL2480 (26), 32.3% homology to the enzyme of
Aeromonas hydrophila AE036 (17), and 19.5%
homology to the enzyme of Stenotrophomonas maltophilia IID1275 (29). On the other hand, the amino acid sequence of the DK4
-lactamase is identical to that of a metallo
-lactamase termed IMP-1 and produced by S. marcescens TN9106
(18). The IMP-1
-lactamase gene
(blaIMP) was previously reported to be located
on the chromosome of S. marcescens. Our detection of
an identical
-lactamase gene incorporated in an R plasmid suggests the insertion of this gene into the chromosome of S. marcescens.
Dose effect of DK4
-lactamase on resistance to
-lactam
antibiotics in E. coli cells.
During the preparation
of the subcloned
-lactamase gene, we observed that the
-lactamase
activity in the E. coli AS226-51 cells was inversely
proportional to the size of the DNA fragment inserted into the vector
plasmid (Table 1). This phenomenon may be
due to the difference in copy number of the plasmid in the host cells
because all the
-lactamase genes were expressed by their own
promoters, and the pDK4 series can be used to provide an understanding
of the dose effect of metallo-
-lactamase production with respect to
the level of resistance of the bacterial cells to
-lactams. The
-lactamase activity of K. pneumoniae DK4 was 0.12 U per
mg of bacterial protein, as determined with cephalothin as a substrate.
When RDK4 was transferred to E. coli AS226-51 cells, the
enzyme activity was 0.098 U per mg of bacterial protein, about 80% of
that for the original strain. For the series of E. coli
subclones, the MICs for the cells increased up to 8 times and the level
of enzyme production increased up to 13 times. The results in Table 1
show quantitatively that the metallo-
-lactamase contributed to the
resistance of the bacteria to all
-lactams except the monobactam
aztreonam.
Characteristics of DK4
-lactamase and its kinetic
parameters.
The DK4
-lactamase was extracted from the E. coli cells carrying pDK4-5 and was completely purified. From 18 liters of the bacterial culture, 18 mg of the purified enzyme protein
was obtained, and its purity was confirmed by SDS-PAGE. The
presence or absence of 0.1 mM zinc sulfate throughout the purification
processes did not affect the recovery of active enzyme,
indicating a tight binding of zinc to the enzyme. The purified enzyme
showed a high degree of thermostability, as the enzyme retained
its full activity even after 30 min of incubation at 60°C in 50 mM
MOPS buffer (pH 7.0) containing 0.1 mM zinc sulfate. The activity was
assayed within 30 s of the enzyme reaction at 30°C. The effect
of pH on the activity of the enzyme against cephalothin at between pH
5.0 and 8.0 was measured in the following buffers: 50 mM MES buffer
with 0.5 M NaCl and 1 mM zinc sulfate (pH 5.0 to 6.5) and 50 mM MOPS
buffer with 0.5 M NaCl (pH 7.0 to 80). The
-lactamase activity
increased concomitantly with pH, such that at pHs 7.0, 6.0, and 5.0 the activities were 75, 49, and 32%, respectively, of that at pH 8.0. The
enzyme was found to be unstable at a pH lower than 6.0, and this
phenomenon may be attributable to the presence of
2-(N-morpholino)ethanesulfonic acid (MES) (8).
Stability at lower pH could be protected by the presence of 1 mM
zinc sulfate. We failed to measure activity at a pH higher than 8.0 because of alkaline hydrolysis of the substrate in the reaction mixture.
The zinc content in the purified enzyme molecule was determined by
means of atomic absorption spectrophotometry. The results indicated
that the DK4
-lactamase contains 2.0 zinc atoms per mature enzyme
protein. Further testing indicated that enzyme activity was not
influenced by the addition of 5 mM zinc sulfate to the reaction
mixture, and for complete inactivation of the enzyme, an EDTA
concentration greater than 1 mM was required. The 50% inhibitory dose
of EDTA was 0.62 mM.
During the UV spectrophotometric assay for enzyme activity, we observed
that the molar extinction coefficient decreased upon the addition of
zinc sulfate. In the case of cephalothin as the substrate, the
coefficient was changed from 7,200 to 6,300 M
1
cm
1 by the addition of 1 mM zinc sulfate. This effect of
zinc could be negated in the presence of 0.5 M NaCl. This phenomenon
may be attributable to an ionic interaction between the zinc cation and
the cleaved
-lactam ring, and it may lead to an erroneous conclusion
that the activity of the metallo-
-lactamase is inhibited by a high
concentration of zinc.
The kinetic parameters of the purified DK4
-lactamase for nine
-lactams were determined in MOPS buffer (pH 7.0) at 30°C, and the
results are summarized in Table 2. The
DK4
-lactamase has a broad substrate specificity, including
penicillins, cephalosporins, cephamycin, and carbapenen,
similar to those of known metallo-
-lactamases. When the kinetic
parameters of the DK4
-lactamase for typical
-lactams were
compared with those for IMP-1 from a more recent report
(13), some differences in the parameters, especially in the
kcat value for ampicillin and
Km values for cephalosporins including
cefoxitin, were observed. The kcat value of the
DK4 enzyme for ampicillin was about 1/16 of that of the IMP-1 enzyme. The Km values of the IMP-1 enzyme for the
cephalosporins were 3 to 46 times greater than those of the DK4 enzyme.
We confirmed that the kinetic data in this paper were reproducible
under the conditions used in the study.
The effects of the serine
-lactamase inhibitors and a renal membrane
dipeptidase inhibitor (cilastatin) on the DK4
-lactamase were
examined. The activity of the DK4 enzyme was not affected by 10 mM
sulbactam, 10 mM clavulanic acid, or 1 mM aztreonam; and it
had undetectable hydrolytic activity against the three
-lactams.
Cilastatin, which is known to be an inhibitor of dipeptidase, showed
weak inhibitory activity against the DK4
-lactamase. The 50%
inhibitory concentration of cilastatin was about 3 mM, and this value
is about 104 times the 50% inhibitory concentration of
cilastatin for dipeptidase (12).
The apo-DK4
-lactamase and its restoration.
A DK4
-lactamase that was missing the two zincs was prepared by 3 days of
dialysis of the EDTA-treated enzyme against zinc-free MOPS buffer. The
enzyme, termed apo-DK4, was completely lacking enzyme activity, and its
activity was estimated to be less than 0.004% of that of the
holoenzyme. The activity of the apo-DK4 enzyme was restored to about
30% of its original activity by the addition of 1 mM zinc sulfate to
the enzyme solution. This restoration was hindered in the presence of a
sulfhydryl reagent, methylmethane thiosulfonate, suggesting the
contribution of a cysteine to zinc binding. The reactivated enzyme had
about the same Km value for cephalothin as that
of the native enzyme, and it was therefore thought that about 70% of
the enzyme molecules were irreversibly denatured during production of
the apoenzyme state.
Functions of His28, His86, His88, His149, His210, and Cys168 as
zinc ligands.
The alignment of the amino acid sequences of the
metallo-
-lactamases indicated that histidines at positions 86, 88, 149, and 210 were conserved in all the enzymes, and a histidine at position 28 was found in some metallo-
-lactamases. All of these histidine residues except His28 were estimated to be located at positions close to the zincs by reference to a three-dimensional structure of a metallo-
-lactamase from B. fragilis
(6). Cys168 was also presumed to be situated in the vicinity
of the zinc. To establish the functions of these residues in the DK4
-lactamase, these five histidines and the cysteine were individually
replaced by an alanine by site-directed mutagenesis, and the mutant
genes on the vector plasmid were transformed into E. coli
AS226-51.
The mutant
-lactamases were purified in the same way as the
wild-type enzyme. All the mutant enzymes except the enzyme with the
H28A mutation showed decreased activity following dialysis against
zinc-free MOPS buffer. Therefore, purification of these mutant enzymes
was carried out in the presence of 0.1 mM zinc sulfate.
The wild-type and His mutant
-lactamases purified were dialyzed in
zinc-free MOPS buffer (pH 7.0) containing Chelex 100 resin. The
wild-type and the mutant with the H28A mutation retained their activities even after the dialysis, and the 2 mol of zinc per mol of
enzyme was detected in the dialyzed enzymes (Table
3). This result agreed with the
metal/enzyme ratio for the wild-type enzyme reported by Laraki et al.
(13).
On the other hand, the enzymes with the H86A, H88A, H149A, and C168A
mutations showed significantly decreased activity, and this residual
activity remained constant 24 h after the dialysis. The zinc
content after exhaustive dialysis of the enzymes with H86A, H88A, H149A
and C168A mutation was about half that of the wild-type enzyme,
suggesting that all the enzymes except that with the H28A
mutation had one zinc atom per one enzyme molecule (Table 3). In the
case of the mutant with the H210A mutation, activity was completely
absent following dialysis, and the zinc content was estimated to be 0.5 mol per enzyme mol. These data suggest a significant distortion of the
active site in the mutant with the H210A mutation.
Cys168 is the only cysteine residue in the DK4
-lactamase. Its
replacement by alanine resulted in a significant lowering of activity,
as measured after enzyme purification, and the missing activity was
only slightly restored even by 1 mM zinc (Table 4). This result is
consistent with that for the mutant of the B. cereus Zn2+
-lactamase with the C168A mutation (19).
On the basis of the fact that serine is situated at position 168 of a
metallo-
-lactamase from S. maltophilla (29), a
mutant with the C168S mutation was prepared from the DK4
-lactamase.
The zinc content of the enzyme with the C168S mutation was 1.07 mol
after dialysis at pH 7.0, but the zinc content was increased to 1.85 mol by dialysis at pH 9.5. This observation suggested that a negative
charge at position 168 is necessary for retention of the second zinc
atom. This assumption was confirmed by the fact that a mutant with a
C168D mutation that we prepared had a zinc content of 2.04 mol after
dialysis at pH 7.0 (Table 3).
The mutant enzymes with the H86A and C168A mutations had detectable
activity even after dialysis, and their Michaelis-Menten constants for
cephalothin were significantly greater than that of the wild-type
enzyme (Table 4). Residual activity in
the mutant enzymes was essentially missing following treatment with 1 mM EDTA. This observation indicated that a little activity may still be
retained in the enzyme lacking one of the two zincs.
View this table:
[in this window]
[in a new window]
|
TABLE 4.
Kinetic parameters of mutant metallo- -lactamases for
cephalothin in the presence or absence of 1 mM
zinc sulfatea
|
|
The enzymes with the alanine substitutions showed increased
specific activity with an increase in the zinc concentration in the
reaction medium. The maximum activity was achieved with 1 mM zinc
sulfate, in the presence of which the enzyme probably retains two zincs
at the active site. The kinetic parameters of the dialyzed enzymes for
cephalothin in the presence or absence of 1 mM zinc sulfate are
summarized in Table 4.
Three histidines at positions 86, 88, and 149 and the cysteine at
position 168 are thought to be the residues that function as zinc
ligands. Alteration of the kinetic parameters of the His mutant enzymes
by the addition of 1 mM zinc sulfate was most remarkable in the cases
of the enzymes with the H86A, H88A and H149A mutations; however, the
activity of the enzyme with the C168A mutation was only slightly
increased in the presence of 1 mM zinc sulfate. The difference in the
effect of zinc between the mutants with the histidine mutations and the
mutant with the cysteine mutation may indicate a difference in the zinc
atom associated with ligands. The mutant enzyme with the C168D mutation
retained two zinc atoms, but its activity could not be detected in the
absence of 1 mM zinc sulfate, suggesting that the zincs combine
irregularly or weakly to the active site. On the other hand, the
mutant enzyme with the C168D mutation exhibited significantly higher
kcat and Km values
than the wild-type enzyme in the reaction medium with 1 mM zinc
sulfate, and its kcat/Km
value was restored up to 70% of that for the wild-type enzyme. It can
be presumed that the kinetic properties of a metallo-
-lactamase are
dependent on the situation of the zincs in the active site.
In order to compare the structural stabilities of the wild type and the
mutants with His mutations, their thermal stabilities were examined.
After various incubation times in 50 mM MOPS buffer containing 0.1 mM
zinc sulfate at 50°C, aliquots of the enzyme solution were withdrawn
and the residual activity was determined. The
-lactamases with the
H86A, H88A, and H149A mutations lost nearly all of their activities
within 20 min of incubation. On the other hand, the wild-type
-lactamase retained its activity, and the
-lactamase with the
H28A mutation had about 60% of its original activity even after 60 min
(data not shown). These observations suggest a close relationship
between structural stability and appropriate binding of the zinc atoms
in the active site.
Lim et al. (14) claimed that His28 of the B. cereus metallo-
-lactamase is essential for enzyme
activity on the basis of the observation that E. coli cells
with the H28Y mutant gene showed high levels of susceptibility to
ampicillin and cephalosporin C (14). In the case of the DK4
-lactamase, we could not observe significant differences in the
enzymatic properties and zinc contents between the wild type and the
mutant with the H28A mutation. It may be concluded that His28 of the
DK4 enzyme is not a functional residue.
Function of Asp90 as a general base in the enzyme reaction.
Aspartic acid at position 90 is one of the conserved residues in known
metallo-
-lactamases. Concha et al. (6) claimed that Asp90
of a metallo-
-lactamase from B. fragilis is one of the
zinc ligands. The B. fragilis
-lactamase with the D90V
mutation, in fact, had a lower zinc content than the wild-type enzyme
(7). We observed that the kcat value
of the DK4
-lactamase increased with an increase in the pH from 5.0 to 8.0, suggesting the existence of a general base in the reaction. A
candidate for the general base was Asp90, which was assumed to be
localized to the active-site area. In order to confirm this assumption,
Asp90 was replaced by asparagine.
The purified
-lactamase with the D90N mutation was extensively
dialyzed against MOPS buffer without zinc, and its zinc content was
determined to be 2.29 mol of zinc per mol of enzyme. Kinetic parameters
of the
-lactamase with the D90N mutation for cephalothin were
determined at pH 7.0 and compared with those of the wild-type enzyme
(Table 5). It was also noted that varying
the zinc concentration in the reaction mixture did not affect the
parameters of either the wild-type or the mutant
-lactamase. The
-lactamase with the D90N mutation showed an approximately 1,000 times lower kcat value for cephalothin than that
of the wild-type
-lactamase; however, no difference in
Km values was detected.
The kcat value was determined from pH 5.0 to 8.0 by using cephalothin as the substrate. Figure
2 shows the effect of pH on the
kcat value, which is expressed as the percentage
of the kcat determined at pH 8.0. The
-lactamase with the D90N mutation exhibited a lower value than the
wild-type enzyme from pH 5.5 to 8.0. This result suggests that Asp90
acts as a general base in the enzyme reaction and is consistent with
the results obtained with the B. cereus 569/H/9
-lactamase (3).

View larger version (15K):
[in this window]
[in a new window]
|
FIG. 2.
Effect of pH on the relative kcat
values of the wild-type and the D90N -lactamases. The following
buffers were used for the assay; 50 mM MES buffers containing 0.5 M
NaCl and 1 mM zinc sulfate (pH 5.0 to 6.5) and 50 mM MOPS buffer
containing 0.5 M NaCl (pH 7.0 to 8.0). The activity was measured with
cephalothin as the substrate. , wild-type enzyme; , enzyme with
D90N mutation.
|
|
 |
ACKNOWLEDGMENT |
This study was supported in part by a grant for the study on
drug-resistant bacteria funded by the Ministry of Health and Welfare of Japan.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Division of
Microbial Chemistry, Faculty of Pharmaceutical Sciences, Chiba
University 1-33, Yayoi-cho, Inage-ku, Chiba University 1-33, Yayoi-cho,
Inage-ku, Chiba 263-8522, Japan. Phone: 81-43-290-2930. Fax:
81-43-290-2929. E-mail: oharak{at}p.chiba-u.ac.jp.
 |
REFERENCES |
| 1.
|
Ambler, R. P.
1980.
The structure of -lactamases.
Philos. Trans. R. Soc. London (Biol.)
289:321-331.
|
| 2.
|
Arakawa, Y.,
M. Murakami,
K. Suzuki,
H. Ito,
R. Wacharotayankun,
S. Ohsuka,
N. Kato, and M. Ohta.
1995.
A novel integron-like element carrying the metallo- -lactamase gene blaIMP.
Antimicrob. Agents Chemother.
39:1612-1615[Abstract].
|
| 3.
|
Bounaga, S.,
A. P. Laws,
M. Galleni, and M. I. Page.
1998.
The mechanism of catalysis and the inhibition of the Bacillus cereus zinc-dependent -lactamase.
Biochem. J.
331:703-711.
|
| 4.
|
Bradford, M. M.
1976.
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.
Anal. Biochem.
72:248-254[CrossRef][Medline].
|
| 5.
|
Carter, P.,
H. Bedouelle,
M. M. Y. Waye, and G. Winter.
1984.
Oligonucleotide-directed mutagenesis in M13. Experiment manual.
Medical Research Council, London, United Kingdom.
|
| 6.
|
Concha, M. W.,
B. A. Rasmussen,
K. Bush, and O. Herzberg.
1996.
Crystal structure of the wide-spectrum binuclear zinc -lactamase from Bacteroides fragilis.
Strucure
4:823-836.
|
| 7.
|
Crowder, M. W.,
Z. G. Wang,
S. L. Franklin,
E. P. Zovinka, and S. J. Benkovic.
1996.
Characterization of the metal-binding sites of the -lactamase from Bacteroides fragilis.
Biochemistry
35:12126-12132[CrossRef][Medline].
|
| 8.
|
Fitzgerald, P. M. D.,
J. K. Wu, and J. H. Tony.
1998.
Unanticipated inhibition of the metallo-lactamase from Bacteroides fragilis by 4-morpholineethane-sulfonic acid (MES): a crystallographic study at 1.85-Å resolution.
Biochemistry
37:6791-6800[CrossRef][Medline].
|
| 9.
|
Hashomoto-Gotoh, T.,
T. Mizuno,
Y. Ogasahara, and M. Nakagawa.
1995.
An oligodeoxyribonucleotide-directed dual amber method for site-directed mutagenesis.
Gene
152:271-275[CrossRef][Medline].
|
| 10.
|
Ito, H.,
Y. Arakawa,
S. Ohsuka,
R. Wacharotayankun,
N. Kato, and M. Ohta.
1995.
Plasmid-mediated dissemination of the metallo- -lactamase gene blaIMP among clinically isolated strains of Serratia marcescens.
Antimicrob. Agents Chemother.
39:824-829[Abstract].
|
| 11.
|
Iyobe, S.,
H. Sagai, and S. Mitsuhashi.
1981.
TN2001, a transposon encoding chloramphenicol resistance in Pseudomonas aeruginosa.
J. Bacteriol.
146:141-148[Abstract/Free Full Text].
|
| 12.
|
Keynan, S.,
N. M. Hooper,
A. Felici,
G. Amicosante, and A. J. Turner.
1995.
The renal membrane dipeptidase (dehydropeptidase I) inhibitor, cilastatin, inhibits the bacterial metallo- -lactamase enzyme CphA.
Antimicrob. Agents Chemother.
39:1629-1631[Abstract].
|
| 13.
|
Laraki, N.,
N. Franceschini,
G. M. Rossolini,
P. Santucci,
C. Meunier,
E. De Pauw,
G. Amicosante,
J.-M. Frere, and M. Galleni.
1999.
Biochemical characterization of the Pseudomonas aeruginosa 101/1477 metallo- -lactamase IMP-1 produced by Escherichia coli.
Antimicrob. Agents Chemother.
43:902-906[Abstract/Free Full Text].
|
| 14.
|
Lim, H. M., and J. J. Pene.
1989.
Mutations affecting the catalytic activity of Bacillus cereus 5/B/6 -lactamase II.
J. Biol. Chem.
264:11682-11687[Abstract/Free Full Text].
|
| 15.
|
Lim, H. M.,
J. J. Pene, and R. W. Shaw.
1988.
Cloning, nucleotide sequence, and expression of the Bacillus cereus 5/B/6 -lactamase II structural gene.
J. Bacteriol.
170:2873-2878[Abstract/Free Full Text].
|
| 16.
|
Marumo, K.,
A. Takeda,
Y. Nakamura, and K. Nakaya.
1995.
Purification and characterization of metallo- -lactamase from Serratia marcescens.
Microbiol. Immunol.
39:27-33[Medline].
|
| 17.
|
Massidda, O.,
G. M. Rossolini, and G. Satta.
1991.
The Aeromonas hydrophilia cphA gene: molecular heterogeneity among class B metallo- -lactamases.
J. Bacteriol.
173:4611-4617[Abstract/Free Full Text].
|
| 18.
|
Osano, E.,
Y. Arakawa,
R. Wacharotayankun,
M. Ohta,
T. Horii,
H. Ito,
F. Yoshomura, and N. Kato.
1994.
Molecular characterization of an entrobacterial metallo -lactamase found in a clinical isolate of Serratia marcescens that shows imipenen resistance.
Antimicrob. Agents Chemother.
38:71-78[Abstract/Free Full Text].
|
| 19.
|
Paul-Soto, R.,
R. Bauer,
J.-M. Frere,
M. Galleni,
W. Meyer-Klaucke,
H. Nolting,
G. M. Rossolin,
D. De Seny,
M. Hernandez-Valladares,
M. Zeppezauer, and H.-W. Adolph.
1999.
Mono- abd binuclear Zn2+- -lactamase; role of the conserved cysteine in the catalytic mechanism.
J. Biol. Chem.
274:13242-13249[Abstract/Free Full Text].
|
| 20.
|
Sakurai, Y.,
K. Tsukamoto, and T. Sawai.
1991.
Nucleotide sequence and characterization of a carbenicillin-hydrolyzing penicillinase gene from Proteus mirabilis.
J. Bacteriol.
173:7038-7041[Abstract/Free Full Text].
|
| 21.
|
Sanger, F.,
S. Nicklen, and A. R. Coulson.
1977.
DNA sequencing with chain-terminating inhibitors.
Proc. Natl. Acad. Sci. USA
74:5463-5467[Abstract/Free Full Text].
|
| 22.
|
Sawai, T.,
M. Kanno, and K. Tsukamoto.
1982.
Characterization of eight -lactamases of gram-negative bacteria.
J. Bacteriol.
152:567-571[Abstract/Free Full Text].
|
| 23.
|
Sawai, T.,
T. Yoshida,
K. Tsukamoto, and S. Yamagishi.
1981.
A set of bacterial strains for evaluation of -lactamase-stability of -lactam antibiotics.
J. Antibiot.
34:1318-1326[Medline].
|
| 24.
|
Senda, K.,
Y. Arakawa,
S. Ichiyama,
K. Nakashima,
H. Ito,
S. Ohsuka,
K. Shimokawa,
N. Kato, and M. Ohta.
1996.
PCR detection of metallo- -lactamase gene (blaIMP) in gram-negative rods resistant to broad-spectrum -lactams.
J. Clin. Microbiol.
34:2909-2913[Abstract].
|
| 25.
|
Takeshita, S.,
M. Sato,
M. Toda,
W. Masahashi, and T. Hashimoto-Gotoh.
1987.
High-copy-number vectors for lacZ alpha-complementation and chloramphenicol- or kanamycin-resistance selection.
Gene
61:63-74[CrossRef][Medline].
|
| 26.
|
Thompson, J. S., and M. H. Malamy.
1990.
Sequencing the gene for an imipenen-cefoxitin-hydrolyzing enzyme (CfiA) from Bacteroides fragilis TAL2480 reveals strong similarity between CfiA and Bacillus cereus -lactamase II.
J. Bacteriol.
172:2584-2593[Abstract/Free Full Text].
|
| 27.
|
Tsukamoto, K.,
K. Tachibana,
N. Yamazaki,
Y. Ishii,
K. Ujiie,
N. Nishida, and T. Sawai.
1990.
Role of lysine-67 in the active site of class C -lactamase from Citrobacter freundii GN346.
Eur. J. Biochem.
188:15-22[Medline].
|
| 28.
|
Viera, J., and J. Messing.
1987.
Production of single-stranded plasmid DNA.
Methods Enzymol.
153:3-11[Medline].
|
| 29.
|
Walsh, T. R.,
L. Hall,
S. J. Assinder,
W. W. Nichols,
S. J. Cartwright,
A. P. Macgowan, and P. M. Bennett.
1994.
Sequence analysis of the L1 metallo- -lactamase from Xanthomonas maltophilia.
Biochim. Biophys. Acta
1218:199-201[Medline].
|
| 30.
|
Yamaguchi, A.,
T. Hirata, and T. Sawai.
1983.
Kinetic studies on inactivation of Citrobacter freundii cephalosporinase by sulbactam.
Antimicrob. Agents Chemother.
24:23-30[Abstract/Free Full Text].
|
Antimicrobial Agents and Chemotherapy, September 2000, p. 2304-2309, Vol. 44, No. 9
0066-4804/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Wang, J., Okamoto, Y., Morishita, J., Tsuboi, K., Miyatake, A., Ueda, N.
(2006). Functional Analysis of the Purified Anandamide-generating Phospholipase D as a Member of the Metallo-beta-lactamase Family. J. Biol. Chem.
281: 12325-12335
[Abstract]
[Full Text]
-
Yamaguchi, Y., Kuroki, T., Yasuzawa, H., Higashi, T., Jin, W., Kawanami, A., Yamagata, Y., Arakawa, Y., Goto, M., Kurosaki, H.
(2005). Probing the Role of Asp-120(81) of Metallo-{beta}-lactamase (IMP-1) by Site-directed Mutagenesis, Kinetic Studies, and X-ray Crystallography. J. Biol. Chem.
280: 20824-20832
[Abstract]
[Full Text]
-
Oelschlaeger, P., Mayo, S. L., Pleiss, J.
(2005). Impact of remote mutations on metallo-{beta}-lactamase substrate specificity: Implications for the evolution of antibiotic resistance. Protein Sci.
14: 765-774
[Abstract]
[Full Text]
-
Docquier, J.-D., Lamotte-Brasseur, J., Galleni, M., Amicosante, G., Frere, J.-M., Rossolini, G. M.
(2003). On functional and structural heterogeneity of VIM-type metallo-{beta}-lactamases. J Antimicrob Chemother
51: 257-266
[Abstract]
[Full Text]
-
Materon, I. C., Palzkill, T.
(2001). Identification of residues critical for metallo-{beta}-lactamase function by codon randomization and selection. Protein Sci.
10: 2556-2565
[Abstract]
[Full Text]